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Abstract
Obesity is now a leading cause of preventable death in the industrialised world. Understanding its genetic influences can
enhance insight into molecular pathogenesis and potential therapeutic targets. A non-synonymous polymorphism
(rs35859249, p.Arg125Trp) in the N-terminal TBC1D1 phosphotyrosine-binding (PTB) domain has shown a replicated
association with familial obesity in women. We investigated these findings in the Avon Longitudinal Study of Parents and
Children (ALSPAC), a large European birth cohort of mothers and offspring, and by generating a predicted model of the
structure of this domain. Structural prediction involved the use of three separate algorithms; Robetta, HHpred/MODELLER
and I-TASSER. We used the transmission disequilibrium test (TDT) to investigate familial association in the ALSPAC study
cohort (N = 2,292 mother-offspring pairs). Linear regression models were used to examine the association of genotype with
mean measurements of adiposity (Body Mass Index (BMI), waist circumference and Dual-energy X-ray absorptiometry (DXA)
assessed fat mass), and logistic regression was used to examine the association with odds of obesity. Modelling showed that
the R125W mutation occurs in a location of the TBC1D1 PTB domain that is predicted to have a function in a putative
protein:protein interaction. We did not detect an association between R125W and BMI (mean per allele difference 0.27 kg/
m2 (95% Confidence Interval: 0.00, 0.53) P = 0.05) or obesity (odds ratio 1.01 (95% Confidence Interval: 0.77, 1.31, P = 0.96) in
offspring after adjusting for multiple comparisons. Furthermore, there was no evidence to suggest that there was familial
association between R125W and obesity (x2 = 0.06, P = 0.80). Our analysis suggests that R125W in TBC1D1 plays a role in the
binding of an effector protein, but we find no evidence that the R125W variant is related to mean BMI or odds of obesity in a
general population sample.
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Introduction
Obesity has become a major cause of morbidity and mortality in
the industrialised world, substantially through the impact on
incidence of type 2 diabetes mellitus and coronary heart disease
[1]. While environmental change has driven the increase in
obesity, genetic contributions may highlight aspects of pathogen-
esis and novel pathways susceptible to new interventions (drug or
nutritional) [2–4].
A non-synonymous polymorphism (rs35859249, C to T) in
TBC1D1, referred here as the R125W variant or 125W risk allele,
has been previously reported to be associated with familial obesity
in women [5], [6]. R125 is conserved as an Arg or Gln in
mammals and locates within the first phosphotyrosine-binding
(PTB) domain of TBC1D1 [5]. Stone et al. [7] initially identified a
predisposition locus at 4 p15–14, in which TBC1D1 locates, to
severe obesity (Body Mass Index (BMI).35 kg/m2) in pedigrees of
US Caucasian females. They analysed 435 pedigrees of European
descent where on average 10 subjects in each family had a
BMI$35 kg/m2. They identified 10 pedigrees from this sample
that had a logarithm (base 10) of odds (LOD) score$1.0 in 4 p15–
14 and found strong evidence for obesity linkage at this locus in
females. However, there was no prior rationale for sex differences
and no gene*sex interaction tests were presented. In a subsequent
study, Stone et al. [5] reported linkage of the TBC1D1 125W risk
allele with severe familial obesity in females only, using the same
10 aforementioned pedigrees. This familial association of the
R125W variant with obesity has since been replicated in a
European cohort consisting of 9,714 French individuals, through
the over-transmission of the 125W allele into obese offspring [6].
Using the 97th percentile as their threshold for obesity, there was a
borderline significant over-transmission of 125W risk allele into
obese subjects (P = 0.05). After stratifying by sex they found
evidence of a familial association in females (P = 0.008) but did not
present any results of a gene*sex interaction test. Neither group
that have observed the associations in families of probands with
extreme obesity have found replication in population samples,
using a sample size of 137 unrelated females (BMI$35 kg/m2)
and 4,634 general population individuals [5], [6].
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TBC1D1 is a Rab-GTPase Activating Protein, which links the
signals generated by insulin and muscle contraction to the
molecular machinery facilitating glucose uptake into muscle cells
[8–10] where the protein is most highly expressed [11]. Expression
of the R125W TBC1D1 mutant in mouse skeletal muscle impaired
insulin-stimulated, but not contractile-stimulated, glucose uptake
[12].
Recent genetic evidence from the Swiss Jim Lambert (SJL)
mouse strain, which express a truncated form of the TBC1D1
protein, suggests that TBC1D1 may have a more direct role in
whole-body energy homeostasis [13] as these mice were lean and
resistant to high fat diet-induced obesity. Depletion of TBC1D1 in
the C2C12 muscle cell line resulted in increased fatty acid uptake
and oxidation, consistent with similar observations in glycolytic
muscles of SJL mice [13]. Furthermore, sequence variation at
TBC1D1 identified it as a major quantitative trait locus in
distinguishing growth characteristics between chickens bred for
meat-producing or egg-laying [14] additionally supporting a role
for TBC1D1 in metabolism and growth.
Given the evidence that the TBC1D1 R125W variant is
associated with familial extreme obesity but does not appear to
be associated with obesity in general population cohorts [5], [6]
together with the physiological relevance of TBC1D1 in regulating
glucose and lipid homeostasis, we set out both to (i) model the
location of R125 in the first PTB domain of TBC1D1 and (ii)
undertake a further study of the familial association of the R125W
variant with obesity in a general population birth cohort of 2,292
white British mother-offspring pairs.
Results
Homology Model of TBC1D1 PTB1 Domain
To gain insight into the molecular impact of an Arg to Trp
substitution we generated homology models of the first PTB
domain of human TBC1D1. The best available template for
homology modelling TBC1D1 PTB1, the PTB domain of AIDA1
(2M38; DOI:10.2210/pdb2m38/pdb), has a sequence identity of
24% which is a little lower than the required$30% required for
reliable fold identification from a single template. However, the
Hidden Markov methods applied in the homology modelling
servers used here confirm that the PTB1 domain possesses the
standard PTB-domain fold. For example, the HHpred E-values
for the top 10 template structures are between 10236 and 10233
and the average of the Ca Root-mean-square deviation (RMSD)
between models built with these templates and 2M38 is 2.25 A˚, i.e.
the same fold in each case. Despite this rather low (,25%)
primary sequence homology to known PTB domain structures,
models of PTB1 generated from three independent servers were
very similar with only 1.2A˚–2.2 A˚ RMSD between the C-alphas of
their secondary structural elements (Table 1). The models differed
more in the prediction of the loop regions (Figure S1), which is
unsurprising given these regions are intrinsically more flexible and
are likely to exhibit an ensemble of rapidly interconverting
conformations in the physiological environment. The homology
model generated by Robetta server, based on the structure of
human Numb-like protein (PDB ID: 3F0W), was determined, by
PROCHECK analysis, to have better geometric quality than the
models created by HHpred/Modeller and I- TASSER servers
(Table S1 and Method S1). The predicted model (Figure 1A)
consists of the core PTB fold, a b sandwich of perpendicular
antiparallel b sheets (b1–b4 and b5–b7) flanked by a C-terminal a
helix (a2), with an additional a helix between b1 and b2. As shown
in Figure 1A, R125 locates within a loop between b6 and b7 with
the side chain capable of orienting towards the cleft formed
between b5 and a2. Numerous structures solved in the presence of
peptides support this groove as a canonical peptide binding site
particularly for the NPX(p)Y/F motif which upon binding directs
the main chain of the peptide towards the b6/b7 loop of the PTB
domain [15]. Given the proximity of R125 to a putative peptide
binding cleft, substitution of a positively-charged, hydrophilic
arginine to a bulky, neutral, more hydrophobic tryptophan could
have significant repercussions on the biological function of this
domain.
Before examining the associations of R125W with phenotypes
in our cohort, we used a range of prediction tools that were
recently evaluated [16] to assess the pathogenicity of the variant.
The conclusions differed, as the Polyphen and SIFT tools
predicted the variant to be harmful, whereas MutPred and
SNPsGO reported it to have a neutral effect (Table 2).
Study Sample Characteristics
8,228 mothers and 9,193 offspring were successfully genotyped
for the R125W variant with a minor allele frequency (MAF) of
9.0% and 8.9% respectively for the 125W allele. The genotype
frequencies for both mothers and children were consistent with
Hardy-Weinberg equilibrium (P = 0.24 and 0.18 respectively).
These MAF in mothers and offspring in our cohort were consistent
with those found in previous general population studies [5], [6].
Table 3 shows the study characteristics. All offspring measure-
ments were taken during the 15+year focus clinic (mean age: 15.5
years; range: 14.3–17.6 years). The adiposity phenotypes mea-
sured were BMI (mean: 21.4 kg/m2, range 14.1 kg/m2–39.7 kg/
m2), waist circumference (mean: 76.5 cm, range 54.3 cm–
125.9 cm) and (Dual-energy X-ray absorptiometry) DXA-assessed
fat mass 14.1 kg (0.6 kg–70.9 kg). Adiposity measurements
differed somewhat between males and females but the magnitude
of these differences was small, despite the low p-values, which
reflected the large sample size for these gender comparisons. For
the mothers, BMI was the only adiposity measurement available;
this was calculated from their self-report of prepregnancy height
and weight given at mean age 27.7 when they were recruited in
early pregnancy (mean BMI = 23.0 kg/m2, range = 12.5 kg/m2–
51.6 kg/m2).
Association between R125W and Adiposity Phenotypes
in ALSPAC
We found no evidence for an association of the R125W variant
with mean BMI at mean age 15.5 years in the ALSPAC offspring
(Table 4). The results of the Kolmogorov-Smirnov test for equality
of distributions suggested there was no difference between the BMI
distributions of the two homozygous genotypes (D = 0.128,
P = 0.813) (Figure 2). After adjustment of multiple testing there
was no strong statistical evidence that R125W was associated with
any of the phenotypes that we examined as continuous traits. We
also found no evidence of an association of R125W with odds of
obesity at age 15.5 years, or that associations differed by sex for
any phenotypes (Table S2 shows sex specific analyses; P for
R125W*sex interaction all.= 0.33). Using the pre-pregnancy
data from 6,684 mothers in the cohort, we found no strong
evidence of association between R125W and mean BMI or odds of
obesity (Table 5).
Familial Association between R125W and Obesity
To investigate the over-transmission of the R125W risk allele
from heterozygous mothers to affected (i.e. obese) offspring or
from affected mothers to heterozygous offspring we applied the
Transmission Disequilibrium Test (TDT). We found no evidence
Evaluations of TBC1D1 p.Arg125Trp
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of an association of R125W with familial obesity for any of the
different thresholds used to define obesity (Table 6).
Discussion
Our homology modelling locates R125 within a region of a PTB
domain predicted to mediate protein-protein interactions; as such
a tryptophan substitution would be anticipated to have deleterious
functional consequences. We found no strong evidence that the
TBC1D1 R125W variant was associated with adiposity phenotypes
in a general population. Furthermore, we did not find any
evidence for association with familial obesity.
The R125W variant of TBC1D1 lies within the first of the two
PTB domains of the protein. No structure of the TBC1D1 PTB
domain is currently available to provide clues as to the role of
R125 in the function of the protein. However, there are several
structures of other PTB domains with sufficient amino acid
sequence homology to allow homology modelling of this region of
TBC1D1. We employed three different modelling algorithms to
obtain a predicted structure. All methods used (i) highlighted R125
Figure 1. Location of R125 in the homology model of human TBC1D1 PTB1. (A) Homology based model of TBC1D1 PTB domain (residues
13–161) predicted by Robetta server (http://robetta.bakerlab.org/). The R125 residue (red) is orientated towards the cleft formed between b5 and a2
(purple). (B) Solved structure of IRS-1 PTB domain (PDB ID: 1IRS, [47]). The IL-4 phosphopeptide (red) lies within the cleft formed between the b5 and
a2 (purple), a type I b turn redirects the peptide such that the phosphorylated Tyr (shown) is orientated towards the b6/b7 loop.
doi:10.1371/journal.pone.0063897.g001
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as being located in a loop formed between two b-sheets within the
PTB domain structure (b6 and b7; Figure 1A) and (ii) oriented the
positively charged guanidinium side-chain of R125 towards the
base of a groove formed between an a-helix (a2) and a b-sheet
(b5). This groove is highly reminiscent of the phosphopeptide
binding groove found in the Shc and Insulin Receptor-1 (IRS1)
PTB domains, where the phosphotyrosine on the peptide interacts
with the guanidinium side-chains of arginine residues found at the
base (compare Figure 1A with the structure of the IRS1 PTB
domain in Figure 1B).
Our modelling suggests that R125 in TBC1D1 plays a role in
the binding of an effector protein, possibly via a mechanism that
involves phosphorylation although it should be noted that several
PTB domains can bind peptide ligands in a phosphorylation-
independent manner [17]. In most mammals this residue is
conserved as an arginine, which is positively charged, however in
some (including the rat) it exists as a glutamine (Q) that is polar but
uncharged. The consequences of an R125Q substitution on the
binding of a peptide ligand are difficult to predict and could be
subtle, however substitution of either amino acid for a tryptophan,
which is a hydrophobic aromatic residue, would be expected to be
highly deleterious to function either by replacing an important
electrostatic interaction by a hydrophobic one, or by significantly
altering the conformational preference of this loop region.
No peptides or proteins have yet been identified that bind to the
N-terminal TBC1D1 PTB domain, though it has been suggested
that the PTB domains of the related protein, AS160 (TBC1D4),
could be involved in dimerisation of the protein [18]. These
possibilities, and the consequences of the substitutions, require
further experimental investigation in the case of TBC1D1. Our
finding of no association between R125W and BMI, other markers
of adiposity or odds of obesity, is consistent with two previous
general population studies [5], [6]. The reason for the lack of
association in general populations when associations have been
found with familial obesity (though not in our study) is unclear.
The association between the 125W allele and familial obesity was
originally identified using linkage analysis amongst pedigrees
primarily consisting of families from Utah [7]. The R125W
variant was enriched in the individuals in 10 of these families
(P = 0.000007) when compared with 846 population controls.
Ethnicity and ancestry are unlikely to explain the difference
between family studies and results from general population cohorts
as the latter are conducted in European origin individuals and the
Utah cohort has an ancestry similar with that of Europeans [19].
Another possible explanation for the difference is that we did
not preselect our case and control cohorts. Stone et al. [5] selected
their case families from either the Health Family Tree Program
[20] or families consisting of patients who had previously
undergone a gastric bypass [21]. They manually selected pedigrees
for their linkage analysis that had at least two affected sisters
(BMI$35 kg/m2) and also carried R125W, while the control
subjects were unrelated and taken from different populations [22].
Meyre et al. [6] selected their pedigrees based on at least one
person having a BMI.35 kg/m2 and a first degree relative with
BMI.30 kg/m2 (435 pedigrees) or pedigrees having at least one
obese child (674 pedigrees). In contrast, our study was population
based and included all mothers and offspring for whom we had
genotype and phenotype data and did not have any inclusion or
exclusion criteria based on BMI. As such, our results cannot be
interpreted as evidence against the previous findings concerning
TBC1D1 [5], [6].
Moreover, if the R125W effect is restricted to, or conditional on,
very high BMI, then we would not have had the statistical power
to detect it. Initially we only had power of 21.21% using the
International Obesity Task Force (IOTF) cut off points analysing
the transmission of the 125W risk allele from mothers to affected
offspring. However, we were able to control/minimise this affect in
our subsequent analyses by using different thresholds for obesity to
increase the number of study participants being analysed. In doing
so, we achieved power of 41.31% using an obesity cut off of 90%.
We also analysed the transmission of the 125W risk allele from
affected mothers to offspring to more extensively evaluate the
hypothesis.
A further limitation of our study is that the maternal pre-
pregnancy BMI was self-reported and therefore is susceptible to
recall error. Since the women will not have been aware of their
genotype this would be non-differential for the association
examined here and would therefore have the statistical expectation
of biasing results towards the null. However, the consistent null
associations in offspring across a range of directly assessed
adiposity measurements could not be explained by this recall
error.
Conclusion
Our protein modelling studies support a plausible role of this
amino acid in the function of the N-terminal TBC1D1 PTB
domain. One initial report and one replication study have
suggested that R125W is associated with familial obesity in
females, though biologically it remains obscure why there should
be a sex difference. Our analyses find no general population effect,
nor trend in our smaller number of high BMI families.
Biochemical studies of the mutant protein and further studies of
families exhibiting extreme obesity may yield further insight.
Table 1. Comparison of homology models generated by
Robetta, HHpred/MODELLER and I-TASSER servers.
Model RSMD
All C alphas
C alphas of secondary
structure*
MODELLER – Robetta 3.8 A˚ 2.0 A˚
MODELLER – I-TASSER 3.4 A˚ 1.2 A˚
I-TASSER – Robetta 4.3 A˚ 2.2 A˚
*Manually determined C alphas of secondary structure correspond to human
TBC1D1 residues 18–56, 61–79, 92–120, 128–136 and 142–162.
doi:10.1371/journal.pone.0063897.t001
Table 2. Evaluation of the predicted pathogenicity of R125W
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Materials and Methods
Homology Modelling
Secondary structure prediction of human TBC1D1 (GenBank
accession number NP_055988.2) with Jpred3 (www.compbio.
dundee.ac.uk/www-jpred/) [23], together with domain coordi-
nates from pfam (http://pfam.sanger.ac.uk/) [24], identified
residues 13–161 to contain secondary structure elements consistent
with a PTB domain topology. Tertiary structure of this region
was predicted by Robetta (http://robetta.bakerlab.org/) [25],
HHpred/MODELLER (http://toolkit.tuebingen.mpg.de/modeller)
[26], [27] and I-TASSER servers (http://zhanglab.ccmb.med.
umich.edu/I-TASSER/) [28], [29] using default parameters.
Root-mean-square deviation (RMSD) values were calculated
from superimposition of modelled structures with InsightII
(Accelrys, San Diego, CA). Geometric quality of the models
was assessed, based on the Ramachandran plot of residues and
main and side chain parameters, using PROCHECK [30].
USCF Chimera (version 1.7; [31]) was used for the structure
visualisation.
Cohort Description
The Avon Longitudinal Study of Parents and Children
(ALSPAC) is a population-based cohort study investigating genetic
and environmental factors that affect the health and development
of children. The study methods are described in detail elsewhere
[32], [33] (http://www.bristol.ac.uk/alspac). Briefly, 14,541
pregnant women residents in the former region of Avon, UK,
with an expected delivery date between 1st April 1991 and 31st
December 1992, were eligible to take part in ALSPAC. There
were 14,062 live born children, 13,988 of whom were alive at 1
year.
Ethical approval was obtained from the ALSPAC Law and
Ethics Committee and the Southmead, Frenchay, United Bristol
Healthcare NHS Trust (UBHT) and Weston Research Ethics
Committees. Written informed consent was obtained from parents
for all measurements made. In total, genotyping was attempted on
DNA from 9,020 mothers and 10,920 offspring. All genotyping
was performed by KBioscience (Herts, UK).
Data Collection
All measurements were taken by a trained research team during
the 15+year focus clinic (mean age: 15.5 years; range: 14.3–17.6
years). Height was measured to the nearest 0.1 cm using a
Leicester Height Measure (Holtain Crosswell, Dyfed) and weight
was measured to the nearest 0.1 kg using Tanita electronic scales.
Waist circumference was measured to the nearest 1 mm at the
mid-point between the lower ribs and the pelvic bone with a
flexible tape. DXA determined fat mass was assessed at the clinic
using a Lunar Prodigy scanner (Madison, WI, USA) with pediatric
scanning software.
At the time of pregnancy ALSPAC mothers were asked in a
mailed questionnaire to retrospectively report their pre-pregnancy
weight and their height; these were used to calculate maternal pre-
pregnancy BMI.
Genotyping
Genotyping of the TBC1D1 variant R125W was undertaken in
9,020 mothers and 10,920 offspring. All genotyping was
performed by KBiosciences (Herts, UK) using their own system
of fluorescence based competitive allele-specific PCR (KASPar).
Details of assay design are available from the KBiosciences website
(http://www.kbioscience.co.uk).
9,193 offspring were successfully genotyped for the R125W
variant. Study participants with a reported (maternal) non-white
ethnic origin (N = 218) were excluded from analyses. A further 72
offspring were removed from analyses as they were either the
second born child or born in a multiple pregnancy. Of the
remaining 8,903 offspring, 4,165 had been successfully measured
for height and weight at the 15+year focus clinic. 3,421 had their
waist circumference measurement taken and 4,153 had a DXA
assessed fat mass measurement recorded.
8,228 mothers were successfully genotyped for the R125W
variant and 10,569 mothers with a reported white ethnic origin
had filled out a questionnaire concerning their pre-pregnancy
Table 3. Study Characteristics in the ALSPAC cohort.
Characteristic Males Females P (no sex difference)
N Mean (SD) N Mean (SD)
Age (years) 2,026 15.5 (0.3) 2,195 15.6 (0.3) 0.03
BMI (kg/m2) 2,007 21.0 (3.3) 2,158 21.7 (3.6) ,0.001
Waist Circumference (cm) 1,598 76.8 (8.6) 1,823 76.2 (8.7) 0.05
DXA Fat Mass (kg) 2,003 10.0 (6.6) 2,150 17.9 (7.6) ,0.001
Maternal Age (years) 3,421 29.0 (4.8) 3,263 28.8 (4.7) 0.04
Maternal Pre-pregnancy BMI (kg/m2) 3,421 23.0 (3.8) 3,263 22.9 (3.9) 0.29
Data are presented as mean (standard deviation), BMI – Body Mass Index; DXA - Dual-energy X-ray absorptiometry; BP – Blood Pressure.
doi:10.1371/journal.pone.0063897.t003
Figure 2. Kernel Density Plot to Show BMI Distribution at mean
age 15.5 years between Homozygous Genotypes.
doi:10.1371/journal.pone.0063897.g002
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BMI. There was an overlap of 6,748 mothers who were included
in both of these groups. A further 64 subjects were removed before
any analysis took place due to missing data of their offspring at the
pregnancy, leaving our sample size at 6,684.
From the 6,684 mothers that were included in our BMI analysis,
2,292 of them had an offspring amongst the 4,165 subjects taken
from the offspring analysis. This meant we had 2,292 mother-
offspring pairs available to investigate for familial association.
Statistical Analysis
We used Pearson’s x2-test amongst all offspring and mothers
separately to examine if the genotype distributions were consistent
with Hardy-Weinberg equilibrium [34]. Direct associations
between the R125W variant and obesity-related phenotypes in
the offspring were assessed by linear regression using an additive
model of inheritance as this was previously described as the most
suitable for R125W [5]. Logistic regression was used to examine
the association of R125W with odds of obesity, again using an
additive model of inheritance. Multiple comparisons were adjusted
for using the Bonferroni correction [35], with a p-value threshold
of 0.0125 being the equivalent of the conventional 0.05. The
Kolmogorov-Smirnov test for equality of distributions [36] was
used to compare the BMI distributions between the two
homozygous genotypes. We used the maternal data to assess the
association between the R125W variant and adult (pre-pregnancy)
BMI and overweight/obesity using linear and logistic models,
respectively. Any possible interaction between genotype and sex in
the offspring analyses was assessed using the likelihood ratio test to
compare two regression models, one which was simply adjusted for
sex and another which also included an interaction term for
genotype*sex. Furthermore, we analysed males and females
separately to verify whether associations appeared similar in males
and females.
We applied the transmission disequilibrium test (TDT) [37] to
investigate familial association between the R125W polymorphism
and obesity. Initially, we used the International Obesity Task
Force (IOTF) cut off points for obesity [38] (BMI = 28.6 kg/m2 in
females and 29.29 kg/m2 in males at age 15.5) and analysed
transmissions between mother and affected child. We repeated this
analysis looking at mother-son and mother-daughter pairs
separately to accommodate for the previous reports associating
the R125W variant with familial obesity in females. It has been
suggested that the TDT suffers from a lower statistical power [39],
[40] compared with case-control studies of unrelated individuals;
however, in our subsequent analysis we used different thresholds
for obesity to increase the number of study participants being
analysed and control/minimise this affect. We extended this work
by classifying the mothers as the affected case and then repeated
our analysis, initially using BMI cut off point of 30 kg/m2.
Stata 12.0 software (StataCorp, College Station, TX) was used
for general statistical analyses.
Handling of Heterozygote Transmissions
There is literature concerning the issue of missing parental data
when testing for family based association [41–43]. However,
techniques involved in these circumstances may incorporate bias
into the study [44]. When using the TDT, including with genotype
data for both parents, there may be ambiguity concerning which
alleles are transmitted from parents who are heterozygous to
offspring who are also heterozygous [45], [46]. Since paternal
Table 4. Association of TBC1D1 R125W genotypes with adiposity phenotypes in the ALSPAC Cohort.
No. of Obs C/C C/T T/T OR/Padd**
N (%) 9,193 7,600 (82.67%) 1,529 (16.63%) 64 (0.7%)
Sex (Male/Female) 9,193 3,949/3,651 800/729 28/36
BMI (kg/m2) 4,165 21.4 (3.5) 21.1 (3.0) 21.1 (2.8) 0.05
Continuous traits Waist Circumference (cm) 3,421 76.7 (8.8) 75.8 (7.8) 74.3 (6.1) 0.02
DXA Fat Mass (kg) 4,153 14.2 (8.4) 13.6 (7.2) 13.7 (7.4) 0.42
Odds of Obesity Lean (BMI,25 kg/m2)* 3,404 2,793 588 23 reference
Obesity (BMI$30 kg/m2) 155 137 17 1 0.63 (0.39–1.01), P = 0.06
Data are presented as mean (standard deviation), BMI – Body Mass Index; DXA - Dual-energy X-ray absorptiometry; BP – Blood Pressure.
*Odd Ratios are calculated in comparison to lean subjects based on the additive model of inheritance. Lean, overweight and obesity cut-offs points are based on IOTF
equivalents for offspring aged 15.5.
**The Bonferroni corrected p-value equivalent to 0.05 is 0.0125.
doi:10.1371/journal.pone.0063897.t004
Table 5. TBC1D1 R125W Genotype Frequencies of Mothers in the ALSPAC Cohort according to Overweight and Obese status.
BMI Category No. of Obs C/C C/T T/T OR/Padd**
N (%) - 6,684 5,540 (82.88%) 1,099 (16.44%) 45 (0.68%)
Association across Genotypes BMI (kg/m2) 6,684 23.0 (3.8) 22.8 (3.9) 23.1 (3.9) 0.19
Odds of Obesity Lean (BMI,25 kg/m2)* 5,261 4,353 (82.74%) 873 (16.59%) 35 (0.67%) reference
Obesity (BMI$30 kg/m2) 366 301 (82.24%) 64 (17.49%) 1 (0.27%) 1.01 (0.77–1.31), P = 0.96
Data are presented as mean (standard deviation), BMI – Body Mass Index.
*Odd Ratios are calculated in comparison to lean subjects based on the additive model of inheritance.
**The Bonferroni corrected p-value equivalent to 0.05 is 0.025.
doi:10.1371/journal.pone.0063897.t005
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genotype data was not available, we used an approach based on
conditional probability, which takes into account the MAF of the
R125W variant, to calculate the probability that the risk allele has
been transmitted to the affected offspring. The approach is
detailed in the supplementary material (Method S2).
Supporting Information
Figure S1 Superimposed homology models of human
TBC1D1 PTB1. Superimposed homology models of TBC1D1
PTB1 (residues 13–161) from Robetta (blue), HHpred/MOD-
ELLER (green) and I-TASSER (orange) servers with the R125
side chain displayed as spheres. Shown in yellow is the PTB
domain of AIDA1 (2M38; DOI:10.2210/pdb2m38/pdb) which
has the highest (24%) amino acid sequence identity to the
TBC1D1 PTB1 domain. UCSF Chimera (version 1.7) was used to
coordinate superimposition of structures utilising the default
parameters of the matchmaker function.
(TIF)
Table S1 Ramachandran Plot analysis, define d by
PROCHECK, of the homology models generated by
Robetta, HHpred/MODELLER and I-TASSER servers.
(DOCX)
Table S2 Average Phenotype measurements according
to TBC1D1 R125W genotypes stratified by Gender in
Offspring in ALSPAC cohort.
(DOCX)
Method S1 Assessing the stereochemical quality of the
individual homology models.
(DOCX)
Method S2 Conditional probability for Heterozygotes.
(DOCX)
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